
AI in Research and Administration
TWINCORE establishes task force

TWINCORE was founded in 2008 by the Helmholtz Centre for Infection Research and the Hannover Medical School. We combine the expertise of medical professionals and scientists from a wide range of disciplines to find answers to the pressing questions in infection research. Our focus: translational research – the bridge between basic science and clinical application.
The LISA Summer School 2026 takes place from 23 August to 11 September 2026. Registration is open until 31 March.

TWINCORE establishes task force

TWINCORE scientist among 95 new Fellows of prestigious academy

OPERA research project launched to further develop antiviral active substances
We conduct translational infection research to improve the prevention, diagnosis and treatment of infectious diseases in humans. We focus on three areas that characterize our research work. Find out here how we proceed and what results we achieve.
Under the leadership of our best scientists, various labs are working on different projects within our research topics.
Prallet S, Maier N, Li A, Afting C, Huang H, Hu J, Toprak E, Keya D, Colasanti O, León-Janampa N, Marlet J, Beisel C, Mogler C, Puchas P, Behrendt P, Boettler T, Steinmann E, Saha S, Laketa V, Lohmann V, Wittbrodt J, Hermann C, Dill M, Dao Thi V
Chhatbar C, Sankowski R, Schulz M, Shimizu T, Schwabenland M, Staszewski O, Scheiwe C, Nessler S, Borst K, Dumas A, Trost E, Berchtold D, Brandão W, Mossad O, Dalmau Gasull A, Frosch M, Erny D, Diebold M, Guffart E, Ternka K, Guranda M, Vinnakota J, Friesen M, Ouk K, Waltl I, LaMorte M, Hammond T, Di Liberto G, Vincenti I, Kreutzfeldt M, Mughrabi I, Al-Abed Y, Blank T, Meyer-Luehmann M, Crow Y, Hagen N, Ofengeim D, Zeiser R, Kettwig M, Gärtner J, Meisel A, Schwemmle M, Kalinke U, Beck J, Bengsch B, Thimme R, Butovsky O, Seredenina T, Ransohoff R, Quintana F, Kierdorf K, Merkler D, Stadelmann C, Priller J, Prinz M
Nguyen N, Zhang Z, Jiang X, van Unen N, Dos Santos J, Zhou L, Matzaraki V, Botey-Bataller J, Blaauw M, Vos W, van Eekeren L, Verbon A, Groenendijk A, Stalenhoef J, Berrevoets M, Joosten L, Netea M, Xu C, van der Ven A, Li Y
The project is researching how the effect of monoclonal antibodies can be improved. These antibodies are already being used successfully against viruses. The aim is to optimize the so-called Fc effector functions in order to fight infections even more effectively.
The project is developing iPSC-based therapies for MSMD patients, a genetic disease with mutations in the IFN-γ signaling pathway that lead to severe mycobacterial infections. The aim is to improve the treatment prognosis.
Population genetic studies show that genetic variability between bacterial strains can influence the evolution of antimicrobial resistance. Using automated laboratory evolution (ALE), we are investigating how genetic backgrounds control AMR evolution.
Monoclonal antibodies are transforming modern medicine. At Helmholtz Infection Medicine Hannover, uniting TWINCORE and CiiM, cutting-edge technologies and AI drive the development of next-generation human antibodies targeting major infectious diseases.
Prof. Dr. Niels Lemmermann
Institut für Virologie
Universitätsklinikum Bonn
“From Virus to T Cells: Antigen Presentation During mCMV Infection”
"Interaction with regulators, e.g. in preparation of a first clinical study"
The seminar covers the principles and tools of "vibe engineering" for using AI coding agents to solve digital problems. Participants will learn how to leverage these agents while understanding and mitigating associated risks to data and intellectual property. The session includes practical examples and guidance for safe implementation.

